Investing.com - Decibel Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Decibel Therapeutics announced earnings per share of $-0.640 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.667 on revenue of $0.00.
Decibel Therapeutics shares are down 16.92% from the beginning of the year and are trading at $3.240 , down-from-52-week-high.
Decibel Therapeutics shares gained 4.18% in intra-day trade the report.
Decibel Therapeutics follows other major Healthcare sector earnings this month
Decibel Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar